MYOS RENS Cash Flow - Quarterly (NASDAQ:MYOS)

Add to My Stocks
$1.42 $0.02 (1.39%) MYOS stock closing price Jun 22, 2018 (Closing)

The financial analysis of MYOS requires an investor to check the cash flows for MYOS RENS. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For MYOS RENS profits one has to check the income statement and for MYOS RENS debt one has to check the balance sheet. MYOS RENS saw a cash impact of $- from the buyback of MYOS shares. The cash flow statement helps in the MYOS RENS stock analysis by providing more information for evaluating changes in assets, liabilities and equities. MYOS RENS had an outflow of $-0.98M from operating activities, $- spend due to financing activities, and $- outflow due to investing activities till 2018 Q1.

View and download details of MYOS RENS cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities--0.26M-0.51M-0.47M-0.41M-0.02M-0.04M--1.3M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net---------1.25M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment------0.38M----0.02M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-2.94M1.92M1.92M1.92M5.14M5.25M5.25M5.25M-
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings------0.1M-0.1M-0.1M-0.1M-
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities--0.1M-0.12M-0.12M-0.12M--0.1M-0.1M-0.1M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year1.86M-1.56M-3.97M-----
Cash & Equivalents at Year End---1.14M2.23M1.86M2.88M3.74M5.21M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The MYOS RENS stock price history and MYOS RENS stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that MYOS RENS is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - MYOS RENS stock price movement.
  • MYOS RENS decreased its cash from operating activities to $-0.98M till 2018 Q1. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $- for MYOS till last quarter 2018 Q1 report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $- for MYOS RENS. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For MYOS RENS Cash Flow

Quarterly Cash Flow Statements For MYOS RENS Technology Inc Peers

Alliqua cash flow, International Stem Cell Corp cash flow, Mateon cash flow, Muscle Pharm cash flow